MediWound (MDWD) Tops Q2 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. WDAY
2. NVDA
3. AAPL
4. JNJ
5. AMAT
6. META
7. NRIX
8. SPY
9. OIG
10. BAC

Go back to MediWound (MDWD) Tops Q2 EPS by 7c

MediWound Reports Second Quarter 2015 Financial Results

August 3, 2015 4:34 PM EDT

YAVNE, Israel, Aug. 3, 2015 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today reported financial results for the three and six months ended June 30, 2015.

Highlights of the second quarter of 2015 and recent weeks include:

Increasing use and adoption of NexoBrid® in key European markets Advancement of U.S. Phase 3 clinical trial of NexoBrid® to treat severe burns Approval by the Israeli Office of the Chief Scientist of first grant to support... More